These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2699128)

  • 1. [Insulin receptors in diabetes mellitus].
    Tankova Ts
    Vutr Boles; 1989; 28(6):8-12. PubMed ID: 2699128
    [No Abstract]   [Full Text] [Related]  

  • 2. [Insulin resistance in type 2 diabetes. Receptor and post-receptor aspects].
    Purrello F; Trischitta V; Vigneri R
    Minerva Endocrinol; 1984; 9(2):221-8. PubMed ID: 6390135
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of diabetes.
    Tripathy BB; Samal KC
    J Assoc Physicians India; 1983 Apr; 31(4):235-40. PubMed ID: 6358183
    [No Abstract]   [Full Text] [Related]  

  • 4. [Insulin receptor and postreceptor disorders: significance for the development and therapy of carbohydrate metabolic disorders].
    Schernthaner G; Prager R
    Acta Med Austriaca; 1984; 11(3-4):70-8. PubMed ID: 6382903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of diabetes in the elderly.
    Redmon JE
    Compr Ther; 1984 Apr; 10(4):24-8. PubMed ID: 6426852
    [No Abstract]   [Full Text] [Related]  

  • 6. [Testing insulin and sulfonylurea sensitivity in type II diabetes mellitus].
    Holländer E
    Orv Hetil; 1984 Dec; 125(51):3103-6. PubMed ID: 6392996
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes.
    Kolterman OG; Olefsky JM
    Diabetes Care; 1984; 7 Suppl 1():81-8. PubMed ID: 6376033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiologic and physiopathologic implications of insulin-receptor interaction (II). Pathologic situations in which changes in insulin-receptor interaction are detected].
    Durán García S; Hernández Herrero C
    Med Clin (Barc); 1984 Apr; 82(14):639-45. PubMed ID: 6376967
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diabetes mellitus. Importance of early diagnosis, appropriate management and control].
    Dtsch Med Wochenschr; 1997 Oct; 122(42 Suppl Diabetes):1-6. PubMed ID: 9368471
    [No Abstract]   [Full Text] [Related]  

  • 10. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
    Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
    Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to insulin.
    Muşeţeanu P; Oprescu S
    Endocrinologie; 1988; 26(3):221-6. PubMed ID: 3062758
    [No Abstract]   [Full Text] [Related]  

  • 12. Intensive management of type II diabetes.
    Duckworth WC
    Postgrad Med; 1991 Mar; 89(4):65-8, 70, 72. PubMed ID: 2000364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin receptors and interference by medication: in vivo and in vitro studies].
    Canivet B; Dolais-Kitabgi J; Freychet P
    Journ Annu Diabetol Hotel Dieu; 1982; ():61-70. PubMed ID: 7047843
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral hypoglycemic agents in the treatment of type II diabetes.
    Tal A
    Am Fam Physician; 1993 Nov; 48(6):1089-95. PubMed ID: 8237731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of diabetes mellitus in "secondary failure of sulfonylurea compounds"].
    Bachmann W
    Med Klin (Munich); 1987 Jun; 82(14):491-4. PubMed ID: 3302644
    [No Abstract]   [Full Text] [Related]  

  • 16. Tube feeding your diabetic patient safely.
    Bak LB; Heard KA; Kearney GP
    Am J Nurs; 1996 Dec; 96(12):47-9. PubMed ID: 8961863
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes mellitus: customizing management.
    Levin PA; McLaughlin J; Kowarski AA
    Hosp Pract (Off Ed); 1984 Oct; 19(10):137-43, 147-9. PubMed ID: 6090485
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical basis for contemporary classification and management of the diabetes syndrome.
    Skillman TG
    Trans Assoc Life Insur Med Dir Am; 1984; 66():44-56. PubMed ID: 6397899
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacologic treatment of diabetes].
    De Montigny P; Clerc C; Descarpentries C
    Perspect Infirm; 2006; 4(2):30-4. PubMed ID: 17184094
    [No Abstract]   [Full Text] [Related]  

  • 20. [Permanent changes in insulin resistance by changes in life style among subjects with impaired glucose tolerance].
    Uusitupa M; Lindi V; Louheranta A; Salopuro T; Lindström J; Tuomilehto J
    Duodecim; 2004; 120(12):1495-7. PubMed ID: 15293711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.